Stryker was hit by a cyberattack this week that knocked out its internal systems worldwide and caused delays to order processing and manufacturing. An Iran-linked group has claimed responsibility for the attack, but the full impact remains unclear.
Shaun Braun, Zimmer Biomet’s chief information and technology officer, said today’s biggest medtech innovation is the field’s focus on connection and interoperability. By integrating data, AI and robotics into a single ecosystem, the company is seeking to deliver more personalized care and improve surgical outcomes.
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
HumoTech has developed a robotic platform that lets patients quickly try multiple prosthetic or exoskeleton options in a clinic, using both objective data and patient feedback to identify the best fit. The technology aims to reduce device abandonment and improve outcomes.
Jennifer Thompson, Medtronic’s vice president of U.S. aortic sales, detailed how AI is transforming medical device commercialization during a fireside chat at Reuters’ MedTech conference. The technology is helping teams identify patients, optimize their sales deployment and discover care bottlenecks.
The cybersecurity process is something you need to invest effort in now. Here's some insight on conducting a security risk analysis that is impactful for the whole life of a medical device or medical device software.
A Johnson & Johnson cancer treatment that can spare certain bladder cancer patients from the radical step of surgical removal of the organ now has FDA approval. J&J’s drug/device combination product, Inlexzo, came from the 2019 acquisition of Taris Biomedical.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit more room to focus and compete in its own crowded market.
Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers.
Click Therapeutics’ migraine mobile app may now be used alongside standard drug therapies as a way to prevent episodic migraine in adults. In clinical trials, daily use of the app led to a statistically significant reduction in monthly migraine days.
Breast cancer survivor Kate Dilligan is the CEO of Cooler Heads, a company that sells a portable and self-administered scalp cooling device. The system helps chemotherapy patients retain their hair, and therefore their self-esteem and privacy.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
A Utah-based startup named Orion Innovations released two studies this month demonstrating its product’s efficacy. The device attaches to hospital IV lines and uses a light to assist nurses with the identification and tracing of medication infusion lines, with the goal of reducing errors.
This week at HLTH, Dexcom COO Jake Leach discussed Stelo, his company's new product. Stelo is an over-the-counter continuous glucose monitor meant for all adults who don't take insulin.
The FDA approved Novocure medical device Optune Luna as a treatment for advanced cases of non-small cell lung cancer. The wearable technology delivers electrical fields that kill cancer cells.
Over the past decade, Abbott and Dexcom — the two largest makers of continuous glucose monitors — have been teaming up with medical device companies that sell automated insulin delivery systems. Industry experts think these partnerships are smart moves to stay relevant in the rapidly-developing diabetes care space.
Abbott recently launched the FreeStyle Libre 3 Plus sensor, which it says is the smallest and most discreet sensor on the market. It will soon be available in U.S. retail pharmacies and medical equipment suppliers.